Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease.
about
Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data.Reduced healthcare utilization following successful hepatitis C virus treatment in HIV-co-infected patients with mild liver diseaseImmunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection.Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting.A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection.The burden of hepatitis C to the United States Medicare system in 2009: Descriptive and economic characteristics.Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States.Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia.Cost/Benefit of Hepatitis C Treatment: It Does Not End with SVR.
P2860
Q30863587-125E42CE-6492-4272-82A5-07B790A5867EQ37046208-29EF70E2-7DB3-44FA-91CA-AC480FF7C513Q37343317-B68B3E7B-0FB8-4AE2-99DE-33236D225B1EQ37354282-E3404BCE-5582-4CE7-8161-F405DE43F833Q37629097-80742D4C-C330-4502-A431-5ECF34F4F910Q39153261-9C576691-374A-4C9F-BCAE-C51AA8354302Q40168920-4C568EE6-55D5-4F51-B4A0-B8A327D803D1Q41366537-43BCADE2-A19C-4B5A-81D6-1A3470D8E570Q47605707-9582616B-D3C8-4142-8707-8279854FC018Q54254113-E8A13350-E74E-45E9-BBFB-31A9DC17740A
P2860
Hepatitis C virus therapy is associated with lower health care costs not only in noncirrhotic patients but also in patients with end-stage liver disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Hepatitis C virus therapy is a ...... with end-stage liver disease.
@ast
Hepatitis C virus therapy is a ...... with end-stage liver disease.
@en
type
label
Hepatitis C virus therapy is a ...... with end-stage liver disease.
@ast
Hepatitis C virus therapy is a ...... with end-stage liver disease.
@en
prefLabel
Hepatitis C virus therapy is a ...... with end-stage liver disease.
@ast
Hepatitis C virus therapy is a ...... with end-stage liver disease.
@en
P2093
P2860
P356
P1476
Hepatitis C virus therapy is a ...... with end-stage liver disease.
@en
P2093
A R Buikema
E J Korner
F M Hamzeh
N A Terrault
P J Pockros
S C Gordon
P2860
P304
P356
10.1111/APT.12454
P407
P577
2013-08-25T00:00:00Z